Global Sterile Injectable Drugs Market Insights and Forecast to 2027

Sterile injectable drugs are sterile, parenteral preparations containing one more Active Pharmaceutical Ingredient (API) intended for administration into the body.
Growth of the global sterile injectable drugs is primarily driven by increasing demand for novel drug delivery systems, rising prevalence of chronic diseases, increasing public private partnerships and also rising awareness towards the use of sterile injectable drugs.

Market Analysis and Insights: Global Sterile Injectable Drugs Market
The global Sterile Injectable Drugs market is valued at US$ 3408 million in 2019. The market size will reach US$ 4878.9 million by the end of 2026, growing at a CAGR of 5.2% during 2021-2026.

Global Sterile Injectable Drugs Scope and Market Size
Sterile Injectable Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Sterile Injectable Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.


Segment by Type
Cytokines
Insulin
Peptide hormones
Vaccines
Immunoglobulins
Blood Factors
Peptide antibiotics
Others


Segment by Application
Cancer
Diabetes
Cardiovascular Diseases
Musculoskeletal
CNS
Infections
Others


By Company
Baxter International
Sanofi
GlaxoSmithKline
AstraZeneca
Merck
Novartis
Pfizer
GILEAD SCIENCES
Johnson & Johnson Services


By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia